Key result
Catheter ablation is an increasingly effective and attractive treatment option for ventricular tachycardia compared to antiarrhythmic drug therapy.
Why the study?
Does catheter ablation improve outcomes compared to antiarrhythmic drug therapy in patients with ventricular tachycardia?
Does catheter ablation improve outcomes compared to antiarrhythmic drug therapy in patients with ventricular tachycardia?
This editorial argues for earlier use of catheter ablation for ventricular tachycardia, highlighting its increasing efficacy compared to the limited efficacy and adverse effects of antiarrhythmic drugs.
Catheter ablation as a treatment for ventricular tachycardia has lagged behind ablation procedures for atrial arrhythmias in becoming an established first-line therapy. Barriers to the study of catheter ablation for ventricular tachycardia are substantial and include technical and procedural challenges, which have contributed to disappointing results and difficulties in evaluating the efficacy of this rapidly evolving procedure. Nevertheless, ablation is an increasingly effective treatment for ventricular tachycardia, and it is a highly attractive option, given the limited efficacy and frequent adverse effects of antiarrhythmic drug therapy. 1-4 The Ventricular Tachycardia Ablation versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease (VANISH) . . .
No takes yet. Share an insight, caveat, or question.
Timothy M. Markman (2025) conducted an editorial in Ventricular tachycardia. Catheter ablation vs. Antiarrhythmic drug therapy was evaluated. Catheter ablation is an increasingly effective and attractive treatment option for ventricular tachycardia compared to antiarrhythmic drug therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: